Stimulant Use and Study Protocol Completion: Assessing the Ability of Men Who Have Sex with Men to Collect Dried Blood Spots for Laboratory Measurement of HIV Viral Load
Teran et al.
The finding, in our words
The study found that stimulant users were less likely to complete an at-home dried blood spot collection protocol than other drug users, but it is feasible to conduct decentralised studies with this population. This matters because it supports the use of patient-centric microsampling in high-risk groups for infectious disease monitoring, despite adherence challenges.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.
In a pilot mixed-methods study of youth with HIV, mailed HemaSpot-HF kits enabled home-based dried blood spot collection that participants found feasible and acceptable, supporting remote viral load monitoring and a self-management model for decentralised care.
Gurung et al., AIDS and behavior (paywalled) · source ↗
This narrative review surveys remote biospecimen collection products for sexual health research, including dried blood spots and volumetric absorptive microsampling, and concludes that successful implementation needs a multidisciplinary, participant-centred team with sufficient time allocated to the complexities of collection procedures and processes.
Horvath et al., AIDS and behavior (paywalled) · source ↗
This pilot study found that while initial household enrolment was low at 9%, remote follow-up was highly feasible, with 88% of respondents, 151 of 172, successfully returning self-collected capillary blood samples after 12 months. This shows that decentralised microsampling is viable for household cohorts when face-to-face contact is restricted.
A study of older rural US patients found that 96 to 98 per cent of self-collected dried blood spot specimens were successfully analysed for HIV viral load, with high acceptability. However, concordance between self-reported and measured viral load was only 69 to 82 per cent, highlighting the value of objective decentralised microsampling over self-reporting.
Walsh et al., AIDS and behavior (paywalled) · source ↗
A 2025 review maps 28 microsampling devices, from dried spots and volumetric absorptive tips to upper-arm liquid capillary collectors, and names what a laboratory must control before their results are used: the haematocrit effect in non-volumetric dried samples, interstitial fluid from finger milking, volume, haemolysis and transport stability. Regulators on both sides of the Atlantic ask for the same two things, a device the patient can use safely and a sample fit for the test.